Vaccines Archive — Page 4 of 14
-
September 7, 2022
VUMC study will evaluate alternative strategies for administering mpox vaccine
Rarely fatal, the mpox virus — spread by close, often skin-to-skin contact — causes a painful, blistering rash, fever, chills and other symptoms. -
July 20, 2022
Vanderbilt team tracks cellular and antibody responses to COVID-19 vaccine
In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine. -
June 16, 2022
VUMC research aids approval of COVID-19 vaccine for young children
The U.S. Food and Drug Administration is expected to authorize Pfizer and Moderna’s COVID-19 vaccines for children as young as 6 months old as early as tomorrow, following the unanimous recommendation by an FDA advisory panel on Wednesday. -
June 1, 2022
RSV vaccine trial enrolling 6- to 24-months-old children
-
May 19, 2022
Panel considers ways to improve vaccine readiness, restore trust
A recent Ethics Grand Rounds, sponsored by the Vanderbilt Center for Biomedical Ethics and Society, explored potential ways to overcome vaccine readiness and restore trust in health care providers. -
May 12, 2022
VUMC-led study finds Moderna COVID vaccine safe and effective for children
-
April 13, 2022
Additional COVID vaccine helps protect transplant patients
Additional booster doses of vaccine against COVID-19 are particularly important for those who are immunosuppressed, namely those who have had solid organ transplants, a new study shows.